Publicaciones en colaboración con investigadores/as de Institut Pasteur (38)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Invasive aspergillosis in liver transplant recipients

    Transplant Infectious Disease, Vol. 25, Núm. 3

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

  2. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: A viewpoint in 2020

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1532-1543

  3. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey

    Mycoses, Vol. 63, Núm. 5, pp. 420-429

  4. Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1

    Science Translational Medicine, Vol. 12, Núm. 542

2019

  1. 2019 ARIA Care pathways for allergen immunotherapy

    Allergologie, Vol. 42, Núm. 9, pp. 404-425

  2. 2019 ARIA Care pathways for allergen immunotherapy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 11, pp. 2087-2102

  3. Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

    Transplant Infectious Disease, Vol. 21, Núm. 5

2018

  1. Prosthetic Valve Candida spp. Endocarditis: New Insights into Long-term Prognosis-The ESCAPE Study

    Clinical Infectious Diseases, Vol. 66, Núm. 6, pp. 825-832

2017

  1. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

    World Journal of Emergency Surgery

  2. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers

    PLoS ONE, Vol. 12, Núm. 4

  3. Multimarker risk stratification approach at multiple sclerosis onset

    Clinical Immunology, Vol. 181, pp. 43-50

2016

  1. Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

    World Journal of Emergency Surgery, Vol. 11, Núm. 1

  2. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9, pp. 1-8

  3. Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9

  4. The current treatment landscape: Other fungal diseases (cryptococcosis, fusariosis and mucormycosis)

    Journal of Antimicrobial Chemotherapy, Vol. 71, pp. ii31-ii36

2014

  1. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 5-26

  2. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 76-98

  3. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 47-75